These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Selective cytotoxicity of antibody-ricin-A-chain conjugate for human tumor B cells. II. Comparison of activity of immunotoxins conjugated with poly- and monoclonal antibodies]. Tonevitskiĭ AG, Zhukova OS, Rakhmanova VA, Arsen'eva EL, Bogacheva GT. Mol Biol (Mosk); 1988; 22(4):911-6. PubMed ID: 3141780 [Abstract] [Full Text] [Related]
26. [Preparation and anti-tumor activity of monoclonal antibody against ascitic mammary tumor MM46 cells]. Takahashi T, Seto M, Hara T. Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):544-50. PubMed ID: 6192760 [Abstract] [Full Text] [Related]
27. Selective cytotoxicity of a ricin A-chain-anti-carcinoembryonic antigen antibody conjugate for a human colon adenocarcinoma cell line. Griffin TW, Haynes LR, DeMartino JA. J Natl Cancer Inst; 1982 Oct; 69(4):799-805. PubMed ID: 6956757 [Abstract] [Full Text] [Related]
28. Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis. Goldmacher VS, Scott CF, Lambert JM, McIntyre GD, Blättler WA, Collnhson AR, Stewart JK, Chong LD, Cook S, Slayter HS. J Cell Physiol; 1989 Oct; 141(1):222-34. PubMed ID: 2528553 [Abstract] [Full Text] [Related]
33. Hormonotoxins: synthesis, characterization and bioefficacy of some defined disulfide linked conjugates of ovine LH with a ribosome inactivating protein, gelonin. Singh V. Indian J Exp Biol; 1991 Oct; 29(10):916-25. PubMed ID: 1814832 [Abstract] [Full Text] [Related]
34. Anti-T cell monoclonal antibodies conjugated to ricin as potential reagents for human GVHD prophylaxis: effect on the generation of cytotoxic T cells in both peripheral blood and bone marrow. Quinones RR, Youle RJ, Kersey JH, Zanjani ED, Azemove SM, Soderling CC, Lebien TW, Beverley PC, Neville DM, Vallera DA. J Immunol; 1984 Feb; 132(2):678-83. PubMed ID: 6606676 [Abstract] [Full Text] [Related]
35. Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates. Fishwild DM, Wu HM, Carroll SF, Bernhard SL. Clin Exp Immunol; 1994 Jul; 97(1):10-8. PubMed ID: 8033405 [Abstract] [Full Text] [Related]
36. Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin. Youle RJ, Neville DM. Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5483-6. PubMed ID: 6968914 [Abstract] [Full Text] [Related]
37. Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by one antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: potential for immunotherapy. Webb KS, Ware JL, Parks SF, Walther PJ, Paulson DF. Cancer Treat Rep; 1985 Jun; 69(6):663-72. PubMed ID: 4040422 [Abstract] [Full Text] [Related]
38. [Selective cytotoxicity of an antibody-ricin A chain conjugate for human tumor cells]. Tonevitskiĭ AG. Mol Biol (Mosk); 1985 Jun; 19(4):1034-41. PubMed ID: 4047033 [Abstract] [Full Text] [Related]
39. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies. Manzke O, Russello O, Leenen C, Diehl V, Bohlen H, Berthold F. Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879 [Abstract] [Full Text] [Related]